We wish to express our deepest condolences for the victims and their families of the Pacific coast of Tohoku Earthquake.
We sincerely hope that the afflicted areas can realize a quick recovery.

News

November 10, 2011
Kowa Announces the Efficacy and Safety of a Novel Phosphodiesterase 3 Inhibitor K-134 for the Treatment of Intermittent Claudication in AHA 2011
August 04, 2011
Mexican health authority has granted marketing authorization for pitavastatin，an HMG-CoA reductase inhibitor or statin，for treatment of hyperlipidemia.
Kowa’s partner，Eli Lilly will market the product as Redevant® from early 2012.
May 11, 2011
The HMG-CoA reductase inhibitor pitavastatin calcium (Livazo 1mg, 2mg & 4mg) has been launched in Spain on May 2, 2011 as the first European market.
Spain is co-marketed by Recordati S.p.A and ESTEVE
May 09, 2011
Kowa Announces the Efficacy and Safety of a Novel Rho Kinase Inhibitor (K-115) in the Treatment of Glaucoma－The Association for Research in Vision and Ophthalmology (ARVO) 2011－

Back numbers